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Abstract
Background: Autophagy is a dynamic process during which isolation membranes package substrates to form
autophagosomes that are fused with lysosomes to form autolysosomes for degradation. Although it is agreed that
the LC3II-associated mature autophagosomes move along microtubular tracks, it is still in dispute if the conversion
of LC3I to LC3II before autophagosomes are fully mature and subsequent fusion of mature autophagosomes with
lysosomes require microtubules.
Results: We use biochemical markers of autophagy and a collection of microtubule interfering reagents to test the
question. Results show that interruption of microtubules with either microtubule stabilizing paclitaxel or
destabilizing nocodazole similarly impairs the conversion of LC3I to LC3II, but does not block the degradation of
LC3II-associated autophagosomes. Acetylation of microtubules renders them resistant to nocodazole treatment.
Treatment with vinblastine that causes depolymerization of both non-acetylated and acetylated microtubules
results in impairment of both LC3I-LC3II conversion and LC3II-associated autophagosome fusion with lysosomes.
Conclusions: Acetylated microtubules are required for fusion of autophagosomes with lysosomes to form
autolysosomes.
Background
Autophagy is the major catabolic pathway for degrada-
tion of dysfunctional organelles and macromolecules.
First characterized in yeast genetically conserved ATG
proteins emerged that participate in and regulate the
process of autophagy. ATG proteins are grouped into 1)
a Class III phosphatidylinositol-3-kinase (PI3K) complex
functioning in vesicle nucleation, 2) a serine-threonine
kinase complex involved in induction of autophagy, and
3) ubiquitin-like protein conjugating systems ATG12
and ATG8 that promote maturation of vesicles [1].
The mammalian homologue of ATG8 is LC3, an
interactive partner of microtubule-associated protein
MAP1A/MAP1B [2,3] and C19ORF5 (Xie R, Nguyen S,
McKeehan K, Wang F, McKeehan WL, Liu L: Microtu-
bule-associated Protein C19ORF5 Bridges Autophagic
Components with Microtubules and Effects Autophago-
somal Biogenesis and Degradation, Submitted).. The
LC3 precursor is truncated to LC3I then conjugated
with phosphatidylethanolamine to membrane-associated
LC3II mediated by the ATG5-ATG12 conjugate [4,5].
The LC3II-associated isolation membranes mature and
fuse with lysosomes to form autolysosomes in which
LC3II is degraded along with the cargo of the autopha-
gosome [6]. The autophagic process can be divided into
autophagosomal biogenesis and autophagosomal degra-
dation based on the fate of LC3 isoforms [7]. Both LC3I
and LC3II are used as markers for autophagy at differ-
ent steps and levels reveal a balance of biogenesis and
conversion/degradation, respectively. Caution is required
to interpret the results from immunoblot since the LC3
levels are dynamically altered [8]. Increasing levels of
LC3I suggest increased production of LC3I and reduced
conversion to LC3II while increasing levels of LC3II
indicate enhanced conversion of LC3I to LC3II and
impaired degradation through lysosomes. For example,
the accumulation of LC3II in cells cultured in Hanks’
media has been interpreted as a consequence of autop-
hagic activation based on the assumption that the capa-
city of lysosomal degradation remains constant [3].
However, such accumulation could also be caused by an
impairment of lysosomal degradation. In order to
* Correspondence: lliu@ibt.tamhsc.edu
Center for Cancer and Stem Cell Biology, Institute of Biosciences and
Technology, Texas A&M Health Science Center, Houston, Texas 77030-3303,
USA
Xie et al. BMC Cell Biology 2010, 11:89
http://www.biomedcentral.com/1471-2121/11/89
© 2010 Xie et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
correctly interpret the LC3 immunoblot data, lysosomal
inhibitor NH4Cl or bafilomycin A1 are used to block
autophagosomal degradation in lysosomes to show the
total amount of converted LC3II during blockade [9-11].
An increase in the total amount of LC3II in the pre-
sence of lysosomal inhibitor indicates an increase of
autophagic influx, e.g. more LC3I production and faster
conversion to LC3II [12].
Microtubules are polymers of tubulin dimers whose
dynamics are regulated by microtubule-associated pro-
teins. They constantly polymerize and depolymerize to
facilitate trafficking of organelles along microtubular
tracks and chromosomal segregation in mitosis [13-17].
After assembly, microtubules are constantly modified in
different patterns to enhance their functions. One type
of modification is acetylation that results in acetylated
microtubules that recruit molecular motors enabling
increased flux of vesicles along microtubular tracks
[18,19]. The mammalian autophagic marker LC3 sug-
gests a potential role of microtubules at multiple stages
in autophagy. The microtubule-associated proteins-
MAP1A/B and C19ORF5 interact with both LC3I and
LC3II and facilitate their association with microtubules,
suggesting an involvement of microtubules in both
autophagosomal biogenesis and degradation [20,21] (Xie
R, Nguyen S, McKeehan K, Wang F, McKeehan WL,
Liu L: Microtubule-associated Protein C19ORF5 Bridges
Autophagic Components with Microtubules and Effects
Autophagosomal Biogenesis and Degradation, Sub-
mitted). Previous reports suggested that microtubules
are required for the trafficking of mature autophago-
somes [11,22,23]. It is still in debate whether microtu-
bules play a role in autophagosomal biogenesis and
subsequent fusion of autophagosomes with lysosomes
depends on microtubules [11,22,23].
To decipher roles and types of microtubules in each
step of autophagy, we applied a set of microtubule inter-
fering reagents and inhibitors of lysosomal activity to
native HeLa cells or HeLa cells stably expressing the
autophagic marker GFP-LC3. Using both biochemical
and cell biological approaches, we found that regular
non-acetylated microtubules are involved in autophago-
somal biogenesis but not required for autophagosomal
degradation. It is the acetylated microtubules that are
required for the fusion of autophagosomes with lyso-
somes to form autolysosomes.
Results
Both stabilization and destabilization of microtubules
impairs autophagosomal biogenesis only in mitotic cells
To investigate impact of microtubules on autophagy, we
created a HeLa cell line stably expressing GFP-LC3 that
mimics native HeLa cell line in autophagic response [9].
As we previously reported [9], fewer GFP-LC3 punctate
foci appeared in premetaphase cells than in interphase
cells (Figure 1A, Ctrl). When lysosomal activity was
inhibited with NH4Cl, both interphase and mitotic cells
dramatically increased numbers of punctate foci of GFP-
LC3 that largely colocalized with MitoTracker-labeled
mitochondria (Figure 1A, Ctrl). Treatment with either
paclitaxel or nocodazole blocked the cells in pre-
metaphase that carry high intensity of GFP-LC3 signals
(Figure 1B). Examination of individual cells under high-
power microscopy revealed that more than 16% of pacli-
taxel-treated mitotic cells contained GFP-LC3 punctate
foci that were colocalized with mitochondria (Figure 1A
and 1C). This suggests that paclitaxel but not nocoda-
zole caused accumulation of GFP-LC3 punctate foci and
the accumulation only occurred in mitotic cells.
The GFP-LC3 pattern described above suggests that
nocodazole increased LC3I levels while paclitaxel
increased LC3II levels since the punctate foci are usually
considered as the LC3II form condensed on autophago-
somal membranes. To confirm the idea, we separated
the fraction enriched in mitotic cells (S) by shakeoff
from the attached fraction that contains both interphase
and mitotic cells (A). Immunoblot analysis revealed
that mitotic cells contained lower levels of LC3II than
interphase cells (Figure 2A, lane 2 vs 1) consistent with
previous reports [24,25]. A blockade of lysosomal degra-
dation with NH4Cl resulted in increased levels of both
LC3I and LC3II to levels that were similar between
mitotic and interphase cells (Figure 2A, lane 3,4 vs 1,2).
From this we concluded in a previous report that basal
levels of autophagy and mitophagy are robust in both
interphase and mitotic cells and most autophagosomes
that form during the entire cell cycle are efficiently
degraded through the lysosomal pathway [9].
Treatment with nocodazole and paclitaxel caused dif-
ferent responses between interphase and mitotic cells.
Treatment with either paclitaxel or nocodazole in inter-
phase cells caused a slight increase in LC3I levels and
no change in LC3II levels in the absence of NH4Cl.
However, there was no change in both LC3I and LC3II
levels in the presence of NH4Cl (Figure 2A and 2B,
white bars). The treatments resulted in a 3-fold increase
of LC3I levels, but no change of LC3II levels in mitotic
cells (Figure 2A, lane 2 vs 6,10, and B, black bars).
Accumulation of LC3I suggested either an increased
synthesis of LC3I through mechanisms related to tran-
scription, post-transcription or translation of LC3 pre-
cursor and conversion to LC3I or reduced conversion of
LC3I to LC3II. The levels of LC3I in interphase cells
were slightly increased (Figure 2A, lane 1 vs 5,9 and B,
white bars) while the levels of LC3I in mitosis were dra-
matically enhanced upon paclitaxel or nocodazole treat-
ment (Figure 2A, lane 2 vs 6,10 and B, black bars).
Although we cannot completely exclude the possibilities
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that more LC3 mRNA molecules were transcribed or
more LC3-I proteins were translated and processed, we
believed that such possibilities were unlikely since both
mRNA transcription and protein translation are gener-
ally suppressed in mitosis. The reduction in total LC3II
in either the paclitaxel or the nocodazole-arrested mito-
tic cells relative to control mitotic cells in the presence
of NH4Cl (Figure 2A, lane 4 vs 8,12 and B, black bars)
further suggested a reduction in net conversion of LC3I
to LC3II. Even though punctate foci appeared in more
than 16% of paclitaxel-treated mitotic cells (Figure 1C),
no difference in LC3II levels was evident. Thus, the
paclitaxel-induced GFP-LC3 punctate foci are likely
made up of aggregates of primarily LC3I. Others using
ATG5-deficient cells have also suggested that that punc-
tate foci containing LC3 do not always represent mature
autophagic structures [8]. The ATG5 gene controls the
conversion of LC3I to LC3II [26] and its deletion causes
accumulation of LC3I. Thus localized accumulation of
LC3I on mitochondrial aggregates appears as punctate
foci that are less than mature autophagosomes. We sug-
gest that the generation of those punctate foci reflect
autophagic failure at the initiation stage rather than
autophagy-independent aggregation (Xie R, Nguyen S,
McKeehan K, Wang F, McKeehan WL, Liu L: Microtu-
bule-associated Protein C19ORF5 Bridges Autophagic
Components with Microtubules and Effects Autophago-
somal Biogenesis and Degradation, Submitted). In sum-
mary, although both paclitaxel and nocodazole impaired
the conversion of LC3I to LC3II resulting in accumula-
tion of LC3I, only in mitotic cells did paclitaxel cause
the accumulation of LC3I in aggregates.
Figure 1 Only paclitaxel causes accumulation of punctate foci of GFP-LC3 in mitotic cells. (A) Accumulation of GFP-LC3 punctate foci in
cells treated with either paclitaxel or nocodazole overnight. Mitochondria are shown in red after exposure to MitoTracker Red CMXRos dye
[32,39]. The punctate foci of bright green GFP-LC3 in stably transfected HeLa cells overlapping with weak red punctate foci of dysfunctional
mitochondria are indicative of mitophagosomes or mitolysosomes (mitochondria-containing autolysosomes). Colocalized punctate foci in white
were revealed by analysis with an ImageJ ColocalizeRGB Plugin. The GFP-LC3 punctate foci overlapping with the much weaker signal of
MitoTracker were not detected in the colocalization analysis. Lysosomal inhibitor NH4Cl (20 mM NH4Cl) was added simultaneously to preserve
the resulting mitophagosomes. Scale bar, 10 μm in all panels. Ctrl, Control, Noc, 10 μM nocodazole; Tax, 10 μM paclitaxel. (B) Fluorescent
intensity of GFP-LC3 in mitotic cells treated with paclitaxel and nocodazole overnight. (C) The percentage of pro-metaphase cells with punctate
foci of GFP-LC3 as shown for the mitotic cells treated with paclitaxel overnight in the absence of NH4Cl (A). Number of cells with GFP-LC3
punctate foci was counted directly and expressed as a percentage of total mitotic cells. Because of the difference in frequency of mitosis, about
100 mitotic cells in 20 to 50 different fields were scored in the presence or absence of nocodazole or paclitaxel, respectively. The data represent
the means and standard errors of three independent experiments. **, p < 0.01 as calculated by Student’s T-test.
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Figure 2 Interrupting the dynamics of regular microtubules with either nocodazole or paclitaxel impairs conversion of LC3I to LC3II
only in mitotic cells. (A) Immunoblot of lysates of fractioned HeLa cells. Mitotic cells were enriched by synchronization with 2 mM thymidine
for 20 hr followed by release from the thymidine blockade for 20 hr in the absence or presence of 10 μM paclitaxel or nocodazole as described
previously [40]. NH4Cl (20 mM) was added simultaneously with microtubule interfering agents. Loosely attached mitotic cells (S) were harvested
by vigorous shake off from the remaining mixture (A) of interphase cells and mitotic cells attached to the dish. (B) The relative intensities of LC3I
and LC3II bands were calculated from the scanned intensities of bands of three independent experiments as exemplified by immunoblot shown
in (A). **, p < 0.01 as calculated by Student’s T-test.
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Paclitaxel, vinblastine and nocodazole differentially
impact microtubular acetylation and structure
Our results above suggest that microtubules affected by
paclitaxel or nocodazole support autophagosomal bio-
genesis but not targeting and fusion with lysosomes.
This is consistent with the report by Fass et al. [11].
However, employment of two microtubule-destabilizers
nocodazole and vinblastine suggest that microtubules
facilitate both autophagosomal biogenesis and fusion of
autophagosomes with lysosomes [22]. We examined
whether the two drugs interfere with microtubular
dynamics differently that might explain the discrepancy.
Acetylated microtubules play an important role in the
anterograde trafficking of vesicles [19]. The impact of
the tubulin-specific histone deacetylase HDAC6 on the
distribution of lysosomes suggested that microtubular
acetylation may be important in autophagosome-
lysosome fusion [27]. When HeLa cells were stained
with a monoclonal antibody against acetylated a-tubulin
that is assembled into acetylated microtubules and a
polyclonal antibody against b-tubulin that builds up reg-
ular microtubules, two sets of microtubular filaments
coexisted with the acetylated microtubules that concen-
trated in the perinuclear region of interphase cells and
on the spindles of mitotic cells (Figure 3A). When HeLa
cells were treated with increasing concentrations of dif-
ferent drugs, the levels of acetylated a-tubulin were dra-
matically reduced in the presence of nocodazole, but
significantly increased in the presence of vinblastine or
paclitaxel (Figure 3B). Examination of the structure of
b-tubulin-labeled regular microtubules revealed that
both nocodazole and vinblastine caused the depolymeri-
zation of regular microtubular filaments. The difference
was that microtubules were depolymerized into a dif-
fused state in the presence of nocodazole and short bar-
like structures in the presence of vinblastine (Figure 3A,
red). In contrast to microtubular depolymerization
caused by nocodazole or vinblastine, paclitaxel stabilized
microtubules as expected (Figure 3A).
The structures containing acetylated microtubules
were affected differently by the drugs (Figure 3A). Regu-
lar microtubules were depolymerised, but some fibrilar
structures of acetylated microtubules remained (Figure
3A, green) although levels of acetylated tubulin were
reduced in the presence of nocodazole (Figure 3B) [28].
Vinblastine caused the depolymerization of not only reg-
ular microtubules, but also acetylated microtubules (Fig-
ure 3A). Therefore, acetylated microtubules were
nocodazole-resistant but vinblastine-sensitive.
Depolymerization of acetylated microtubules causes
accumulation of punctate foci containing GFP-LC3
Although both vinblastine and paclitaxel increased levels
of acetylated a-tubulin (Figure 3B), vinblastine, but not
paclitaxel caused depolymerization of acetylated micro-
tubules. Coincident with the breakdown of acetylated
microtubules by vinblastine, the majority of vinblastine-
treated cells accumulated GFP-LC3 punctate foci that
were colocalized with the dot-like signals of acetylated
tubulin paracrystals (Figure 4A). Under the same condi-
tion, no significant more GFP punctate foci were formed
upon the treatment in the autophagy-defective cell line
expressing GFP-ΔLC3 (Figure 4B). Less than 10%
untreated or nocodazole-treated GFP-LC3 expressing
cells and less than 5% untreated or either nocodazole or
vinblastine-treated GFP-ΔLC3 expressing cells accumu-
lated GFP punctate foci (Figure 4C). When lysosomal
activity was blocked with another lysosomal inhibitor
bafilomycin A1, a large number of GFP-LC3-containing
punctate foci accumulated in the untreated or nocoda-
zole-treated cells (Figure 4A) as expected due to the
robust basal levels of autophagy [9] while only a few
cells expressing the mutant GFP-ΔLC3 accumulate GFP
punctate foci (Figure 4B,C). These punctate foci repre-
sent true autolysosomes formed through the autophagic
machinery that are normally degraded by enzymes in
lysosomes in the absence of lysosomal inhibitor. The
dramatic difference in the intensities of acetylated
microtubules between the untreated and nocodazole-
treated cells did not change the number of cells carrying
GFP-LC3 punctate foci (Figure 4C). This suggested that
a minimal number of intact acetylated microtubules are
sufficient to meet demands of trafficking of autophago-
somes and lysosomes in order to achieve fusion.
Vinblastine-induced accumulation of GFP-LC3 punctate
foci suggests a blockade of disposal of autophagosomes
The vinblastine-induced accumulation of GFP-LC3 punc-
tate foci may be caused by an activation of autophagoso-
mal biogenesis, a blockade of autophagosomal
degradation, or a blockade of conversion of LC3I to LC3II
and accompanying localized aggregation of LC3I as indi-
cated by the paclitaxel-induced accumulation of GFP-LC3
punctate foci in mitotic cells (Figure 1 and 2). To distin-
guish these possibilities, lysates from cells exposed to the
different drugs were analyzed by immunoblot. Consistent
with the accumulation of GFP-LC3 punctate foci, vinblas-
tine treatment in the absence of lysosomal inhibitor
caused a dramatic increase in levels of LC3II and P62,
another autophagic marker directly being involved in
selective autophagic degradation of ubiquitinated protein
aggregates [29] (Figure 5A and 5B, black bars, -BAF). This
suggested either an activation of autophagic biogenesis or
an inhibition of autophagosomal degradation. Less LC3II
and P62 accumulation in the vinblastine-treated cells in
the presence of bafilomycin A1 (Figure 5A and 5B, black
bars +BAF) confirmed an inhibition of autophagosomal
degradation. The cells treated with 100 μM of vinblastine
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Figure 3 Impact of paclitaxel, vinblastine and nocodazole on microtubular acetylation and structure. (A) Immunostaining of microtubules
in HeLa cells untreated or treated with 10 μM of nocodazole, vinblastine or paclitaxel overnight with antibodies against acetylated a-tubulin and
normal b-tubulin. Ac-Tub, acetylated a-tubulin. b-Tub, b-Tubulin. Vin, vinblastine. (B) Immunoblotting analysis of acetylated a-tubulin levels in
lysates of HeLa cells treated with different concentrations of nocodazole, vinblastine and paclitaxel for overnight.
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Figure 4 Vinblastine-induced depolymerization of acetylated microtubules is coincident with accumulation of GFP-LC3 punctate foci.
(A, B) Accumulation of GFP punctate foci in HeLa cells stably expressing GFP-LC3 (A) or GFP-ΔLC3 (B) untreated or treated with either
nocodazole or vinblastine in the absence or presence of lysosomal inhibitor bafilomycin A1 (BAF) overnight. The acetylated microtubules are
counterstained with anti-acetylated a-tubulin antibody. (C) Percentage of GFP expressing cells with more than 10 GFP punctate foci. Only GFP
punctate foci occupying an area with diameter greater than four pixels (~0.15 μm) were counted. The data is the average and standard
deviation of three independent experiments. **, p < 0.01 as calculated by Student’s T-test.
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contained similar levels of LC3II, but application of bafilo-
mycin A1 cut P62 in half (Figure 5). These results suggest
that autophagosome degradation has been completely
inhibited with the high concentration of vinblastine. The
reduction in P62 may reflect alternative pathways such as
the ubiquitination-proteasome pathway that remains
active when autophagy is blocked. In addition, since vin-
blastine depolymerized both acetylated and regular micro-
tubules (Figure 3A), the efficiency of conversion of LC3I
to LC3II was simultaneously reduced in its presence so
that the total amount of LC3II generated during the block-
ade was reduced (Figure 5A and 5B, black bars +BAF).
The vinblastine-induced blockade of autophagosomal
degradation occurs just prior to autophagosome-
lysosome fusion
To further confirm how vinblastine-induced depolymeri-
zation of acetylated microtubules caused the blockade of
autophagosomal degradation, we examined the colocali-
zation of GFP-LC3 punctate foci with lysosomes.
Neither nocodazole nor vinblastine did not increase the
total amounts of lysosomes indicated by LAMP2, a lyso-
somal membrane-associated protein [30] (Figure 6A).
Treatment with bafilomycin A1 caused inhibition of
lysosomal activity, but did not change the amount
of lysosomal vesicles or LAMP2 levels dramatically
(Figure 6A). When lysosomal activity was inhibited, a
large number of autolysosomes resulted from fusion of
GFP-LC3-labelled autophagosomes with lysosomes were
preserved in the control and nocodazole-treated cells
causing overlap of more than 50% of GFP-LC3 punctate
foci with LAMP2 signal (Figure 6B and 6C). In contrast,
vinblastine reduced overlap to less than 20% (Figure 6B
and 6C) when the amount of lysosomes were not
increase (Figure 6A). This suggested that vinblastine-
induced depolymerization of acetylated microtubules
impairs the fusion of autophagosomes with lysosomes to
form autolysosomes.
Discussion
To form mature autophagosomes, microtubule-
associated LC3I is translocated to sites where it is conju-
gated with phosphatidylethanolamine to become LC3II
that is inserted into isolation membranes [4,5]. The iso-
lation membrane may be pre-assembled in some uni-
dentified subcellular location and transported to sites
where substrates and potential cargo exist. Alternatively,
small fragments of isolation membrane or some pre-
autophagosomal structure may be transported to sites
where substrates exist to assemble autophagosomes.
Pre-assembled isolation membranes may also remain on
site waiting for substrates to appear, or both isolation
membrane and substrates may be moved to sites such
as microtubule organizing centers to form mature
autophagosomes [31]. Independent of the precise
mechanism cytoskeletal elements are required for the
trafficking of pre-autophagosomal structures, substrates
and cargo and mature autophagosomes.
Although both directly bind to the same b-tubulin
subunit, paclitaxel prevents while nocodazole promotes
depolymerization of normal microtubules. Treatment
with either of them results in a similar impact on autop-
hagy. There is no obvious influence on interphase cells
cultured under normal conditions, but a similar inhibi-
tory effect on the conversion of LC3I to LC3II in mito-
tic cells. This suggests that basal levels of autophagy are
highly efficient and independent of the status of regular
microtubules so that interruption of the dynamics of
regular microtubules causes no dramatic impact on
overall autophagic influx under steady state conditions.
However, consistent with its short duration, but extreme
vulnerability to damaged organelles and particularly
Figure 5 Only vinblastine causes a blockade of LC3II and P62
degradation. (A) A representative immunoblot of lysates of HeLa
cells treated with different concentration of drugs in the absence or
presence of lysosomal inhibitor bafilomycin A1 overnight. P62, P62
(SQSTM1). (B) Plots of the relative intensity of LC3II and P62 bands
detected from three independent blots as represented by the one
shown in (A). **, p < 0.01 as calculated by Student’s T-test.
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mitochondria [32], autophagic flux appears to intensify
during mitosis [11]. Increased flux makes the conversion
of LC3I to LC3II a rate-limiting step so that it is highly
responsive to deviations in normal dynamics of microtu-
bules induced by either paclitaxel or nocodazole Inhibition
of the conversion of LC3I to LC3II leads to accumulation
of LC3I and reduction of total amount of LC3II. This is
consistent with the report that autophagosomes can be
formed in the absence of intact regular microtubules, but
at a significantly lower extent [11].
After autophagosomes mature, they fuse with lysosomes
to form autolysosomes. Lysosomes distribute throughout
the cytoplasm through anterograde and retrograde move-
ment [33]. Our results show that regular non-acetylated
microtubules seem to play no role in the process since
their interruption did not cause accumulation of LC3II in
Figure 6 Vinblastine blocks autophagosome-lysosome fusion on acetylated microtubules. (A) Immunoblotting analysis of LAMP2 levels in
HeLa cells treated with different concentrations of nocodazole and vinblastine in the absence or presence of bafilomycin A1 overnight.
(B) Colocalization analysis of GFP-LC3 punctate foci with lysosomal marker LAMP2 in HeLa cells stably expressing GFP-LC3 treated with
nocodazole or vinblastine in the presence of bafilomycin A1 overnight. LAMP2 was visualized with anti-LAMP2 primary antibody and
Rhodamine-conjugated secondary antibody. The overlapping analysis was performed with the ImageJ ColocalizeRGB Plugins. (C) The fraction of
GFP-LC3 overlapping with LAMP2 staining as calculated from images shown in (B) with the ImageJ JACoP Plugins. The data shown is the
average and standard deviation of ten randomly selected images in a field of 512 pixels × 512 pixels (23.5 μm × 23.5 μm). The significance of
differences was determined by Student’s t-test.
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the absence of lysosomal inhibitor. This indicates the pre-
sence of highly specific cytoskeletal elements are involved
in the trafficking of autophagosomes and lysosomes
involved in autophagy.
HADC6 is a microtubular deacetylase and regulates
microtubule stability [34]. Inhibition of HADC6
enhances microtubular acetylation leading to antero-
grade trafficking of lysosomes away from centrosomes
in addition to an inhibition of autophagosomal biogen-
esis [18,27,35]. Since microtubular acetylation causes the
recruitment of the molecular motors dynein and kine-
sin-1 to microtubules [18,19], acetylated microtubules
may serve for not only the kinesin-dependent antero-
grade trafficking but also the dynein-dependent retro-
grade trafficking of either lysosomes or autophagosomes.
In addition to the opposite roles in polymerization/
depolymerization of regular microtubules by direct bind-
ing to b-tubulin, paclitaxel and nocodazole have oppo-
site effects in the acetylation of a-tubulin and
stabilization of acetylated microtubules [28]. Paclitaxel
enhances, but nocodazole inhibits a-tubulin acetylation
and stabilization of acetylated microtubules. However,
both of them fail to block autophagosomal degradation.
Both paclitaxel and vinblastine enhance the levels of
a-tubulin acetylation, but exhibit opposite effects on the
polymerization of acetylated microtubules and also
opposite roles in autophagosomal degradation. These
results suggest that it is not the levels of acetylated a-
tubulin that affect autophagosomal degradation. Similar
to paclitaxel, nocodazole does not damage the integrity
of acetylated microtubules although the total levels of
acetylated a-tubulin are reduced [36]. Vinblastine
enhances the levels of acetylated a-tubulin, but causes
depolymerization of both regular and acetylated micro-
tubules. The treatment not only blocks fusion of LC3II-
assoiated autophagosomes with lysosomes, but also
reduces efficiency of the LC3I to LC3II conversion simi-
lar to paclitaxel or nocodazole. It seems that regular
microtubules are involved in, but not essential for the
conversion of LC3I to LC3II and degradation of LC3II
while acetylated microtubules are required for trafficking
of either mature autophagosomes or lysosomes. When
autolysosomes were preserved by treatment with bafilo-
mycin A1, a dramatic decrease of number of autolyso-
somes was observed in cells treated with vinblastine.
Our results also confirmed reports [22] that lysosomes
may be enriched around centrosomes [27], but the
fusion of autophagosomes with lysosomes is not neces-
sarily only around centrosomes.
Based on results from nocodazole treated cells, Fass
et al. concluded that microtubules do not support
autophagosomal targeting and fusion with lysosomes
[11]. As we show here, while nocodazole treatment only
causes depolymerization of non-acetylated microtubules,
a significant portion of acetylated microtubules are resis-
tant to the treatment. Our current results together with
previous reports [9] suggest that cells, particularly in
mitosis, have developed a highly-efficient autophagic
machinery so that a small fraction of intact acetylated
microtubules are sufficient to support fusion and clear-
ance. Thus, nocodazole treatment cannot block the
acetylated microtubule-mediated targeting and fusion of
autophagosomes with lysosomes. Based on results from
cells treated with vinblastine and nocodazole, Kochl et
al. [22] emphasized the importance of microtubules, but
did not dissect the roles of different subtypes of micro-
tubules in the fusion of autophagosomes with lysosomes.
The increase in number of GFP-LC3 punctate foci after
vinblastine blockade was interpreted as a stimulation of
autophagosomal biogenesis rather than a blockade in
clearance [22]. Our results support the idea that the vin-
blastine-induced increase in number of GFP-LC3 punc-
tate foci is the consequence of autophagosomal
accumulation induced by block of autophagosomal
fusion with lysosomes and further degradation in lyso-
somes rather than the stimulation of autophagosomal
biogenesis. Since regular microtubules are not essential
for autophagosomal biogenesis, the increase of autopha-
gosomal number after vinblastine treatment is more
likely caused by continued autophagosomal biogenesis
and a blockade of autophagosomal degradation. How-
ever, the low degree of overlap of autophagosomes and
lysosomes in the presence of high concentrations of
nocodazole could be interpreted as the result of nocoda-
zole-induced efficiency of autophagosomal biogenesis
rather than a blockade of autophagosome-lysosome
fusion as suggested [22]. Although the overnight incuba-
tion of microtubule interfering agents in our experiment
is longer than the reported two hours [22], the fact that
continuous incubation generates no significant more
autophagosomes after the 30-minute period of initial
incubation suggests that prolonged treatment may cause
no significant difference. Since basal levels of autophagy
is robust in the entire cell cycle [9], we tested the effects
of microtubule-interfering agents on basal autophagy
instead of the starvation-induced autophagy as reported
[22]. Their result that the effects of microtubule-inter-
fering agents dominate over the starvation-induced
effect also suggests whether induced autophagy or basal
autophagy is not critical for the investigation of roles of
microtubules in autophagy.
Conclusions
Paclitaxel enhances tubulin acetylation and stabilizes
microtubules. Nocodazole depolymerizes non-acetylated
microtubules and impairs tubulin acetylation, but does
not affect polymerized acetylated microtubules. Vinblas-
tine is able to depolymerize both acetylated and
Xie et al. BMC Cell Biology 2010, 11:89
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non-acetylated microtubules, but enhances tubulin acet-
ylation. The autophagic responses to the treatments of
different microtubular interfering agents reveal that reg-
ular non-acetylated microtubules regulate the efficiency
of but are not essential for the conversion of LC3I to
LC3II. Acetylated microtubules are required for LC3II
degradation.
Methods
Reagents and antibodies
Microtubule interfering reagents paclitaxel, nocodazole
and vinblastine sulfate salt, and lysosomal inhibitor bafi-
lomycin A1 and ammonium chloride (NH4Cl) were
purchased from Sigma. Monoclonal antibodies against
b-actin (c4), acetylated-tubulin (6-11B-1) and LAMP2
(H4B4), polyclonal antibody against b-tubulin (H-235),
and FITC- and Rhodamine-conjugated secondary anti-
bodies were purchased from Santa Cruz Biotechnology,
Inc. Polyclonal antibodies against LC3 and P62
(SQSTM1) were from Nuvus Bio and ENZO Life
Science, respectively.
Immunoblot analysis
Unless otherwise indicated, lysates were prepared in lysis
buffer from cells treated with different drugs overnight,
specific times and cell fractions enriched for mitotic or
interphase cells as described [32,37]. Immunoblots were
prepared from equal amounts of samples separated on
SDS-PAGE and analyzed with the indicated antibodies.
b-actin served as loading control. Protein band profiles
were detected with the Amersham™ ECL™ Plus detection
system and a series of images with different exposure
times were archived. Data presented in the text for
immunoblot or immunohistochemical analysis were
representatives of at least three independent experi-
ments. Some bands necessarily appear overexposed
because of attempts to display the weakest band. Rela-
tive intensities of bands were calculated using ImageJ
from scanned images of the respective immunoblot in
the linear range and adjusted based on the respective
b-actin intensity. The intensity of bands in controls was
assigned a unit of 1.
Immunofluorescence analysis
A stable HeLa cell line expressing GFP-LC3 fusion pro-
tein [38] was established as described [9] As described
[3], we established a stable HeLa cell line expressing
GFP fusion of a mutant version of LC3 (GFP-ΔLC3)
that carries a deletion of the 22 amino acid residues of
LC3 C-terminus and has the lipid conjugation site Gly-
cine at residue number 120 mutated into Alanine so
that it exhibits defective in autophagy initiation. Spread
mono-layered interphase cells and round mitotic cells
were visualized with a Zeiss LSM510 laser confocal
system. GFP-LC3 labeled autophagosomes, MitoTracker
Red CMXRos (MitoTracker) labeled mitochondria, pri-
mary antibody and corresponding FITC or Rhodamine-
conjugated secondary antibody were used to visualize
microtubules and lysosomes [32,38]. We specifically
demonstrated the relationship between chromosomes
and GFP-LC3 previously [9]. Here we used 4’,6-diami-
dino-2-phenylindole (DAPI) instead of TOPRO-3 to
label chromosomes and identify different stages of the
cell cycle so as to avoid the interference of TOPRO-3
signal to red fluorescent signals. The empty spaces
devoid of GFP-LC3 observed in mitotic cells consisted
of condensed chromosomes [9]. The chromosomes in
paclitaxel-arrested premetaphase cells are closely
mingled with GFP-LC3 signals. The staining with Mito-
Tracker generated some diffused and saturated signals
in addition to mitochondria, but colocalization of mito-
chondria with GFP-LC3 punctate foci were shown to be
authentic using higher resolution images [9]. The
acquired images were exported to Adobe Photoshop,
processed and then imported into ImageJ for RGB split
and colocalization analysis with a ColocalizeRGB Plugin.
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